Hemophilia A is an X-linked, hereditary bleeding disorder caused by the absence or defect of a blood clotting protein, Factor VIII. As a result, when a person with hemophilia A has a bleeding episode, the bleeding may be prolonged due to the body's inability to form blood clots. Patients who are affected with hemophilia A experience frequent spontaneous bleeding, most commonly into their joints and soft tissues, with bleeding into vital organs that may ... be life-threatening. Bleeding episodes may be painful, and over time, recurrent joint bleeding may result in debilitating destruction of the joints. Currently, patients with hemophilia A are dependent on injections of Factor VIII produced by genetic engineering or purified from human plasma, to help control a bleeding episode. It is estimated that approximately 50,000 individuals worldwide are affected with hemophilia A.
Hemophilia A - Clotting Factor VIII
Hemophilia B - Clotting Factor IX
Hemophilia C - Clotting Factor XI
There no cure for hemophilia. It can be controlled. Typically there is a deficiency of a clotting factor, therefore the individual must have regular infusions of this deficient factor.
Hemophilia is caused by a deficiency of clotting factor VIII (hemophilia A) or clotting factor IX (hemophilia B).
There are two types of hemophilia: hemophilia A (sometimes called classical hemophilia) and hemophilia B (sometimes called Christmas disease). Both are caused by a low level or absence of one of the proteins in the blood (called factors) that control bleeding. Hemophilia A is caused by a deficiency of factor VIII, and hemophilia B is caused by a deficiency of factor IX. There is no difference between the two types of hemophilia, except that hemophilia B is about five times less common than hemophilia A.
In the most common type, Hemophilia A, the person lacks clotting factor VIII. In Hemophilia B, clotting factor IX is lacking.
Hemophilia is a genetic disorder caused by a deficiency or defect in clotting factor VIII (hemophilia A) or factor IX (hemophilia B). These clotting factors are essential for blood clot formation, and their deficiency leads to prolonged bleeding and poor clotting ability.
Hemophilia is broken into three subcategories; Hemophilia A, Hemophilia B, and Hemophilia C. These subcategories designate a person as having a deficiency of one of three specific clotting proteins. Hemophilia A is the deficiency of the protein called Clotting Factor VIII. Hemophilia B is the deficiency of Clotting Factor IX. Hemophilia C is the deficiency of Clotting Factor XI. "Royal" hemophilia is simply a reference to Hemophilia B and is therefore a result of a deficiency in the Clotting Factor IX protein. It is sometimes called the royal disease because it has been known to have been passed through some royal families throughout history.
Hemophilia is caused by mutations in genes located on the X chromosome that are responsible for producing blood clotting factors. In particular, mutations in the genes for factor VIII or factor IX can lead to hemophilia A or hemophilia B, respectively. These mutations result in deficient or dysfunctional clotting factors, leading to impaired blood clotting and increased bleeding tendencies.
replace the clotting factor in the veins
There are three types of hemophilia: A, B, CQueen Victoria was a carrier of hemophilia B.Proteins are blood-clotting factors that hemophiliacs lack.Hemophilia A is Clotting Factor VIII deficiency.Hemophilia B is Clotting Factor IX deficiency.Hemophilia C is Clotting Factor XI deficiency.Hemophiliacs do not bleed more than other people, they simply bleed longer.Hemophilia is NOT contagious.
Hemophilia is a group of hereditary bleeding disorders characterized by a deficiency in clotting factors, specifically factor VIII (hemophilia A) or factor IX (hemophilia B). These deficiencies result in prolonged bleeding episodes, especially in response to injury or trauma. Treatment typically involves replacement therapy to restore the missing clotting factor.
The main treatment for hemophilia is called replacement therapy. Concentrates of clotting factor VIII or clotting factor IX are slowly dripped or injected into a vein.
Standards of care for Hemophilia vary greatly around the world and from one doctor to another there are variations of care. Most doctors agree treatment of Hemophilia is administration of anti-hemophiliac factor. The main treatment for hemophilia is called replacement therapy. Concentrates of clotting factor VIII (for hemophilia A) or clotting factor IX (for hemophilia B) are slowly dripped in or injected into a vein. These infusions help replace the clotting factor that's missing or low.